DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Protein Kinase TargetsProtein Kinase Targets
  5. /ALKALK
  6. /ZilurgisertibZilurgisertib
Chemical structure of CAS 2173389-57-4

Zilurgisertib

In Stock•Starting at $335 for 1 mg
CAS No.2173389-57-4
MDL No.N/A
MFC30H38N4O3
MW502.60
InChI KeyKPRPFTOLWQQUAV-OCVAFRRMSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mgTo Be Confirmed$335In Stock
5 mgTo Be Confirmed$839In Stock
10 mgTo Be Confirmed$1181In Stock
25 mgTo Be Confirmed$1754In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2173389-57-4
Product NameZilurgisertib

Associated Conditions

fibrodysplasia ossificans progressiva·myelophthisic anemia·kidney disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Pharmacokinetics of Zilurgisertib With and Without Food from Single and Multiple Ascending Dose Phase 1 Studies in Healthy Adults.

European journal of drug metabolism and pharmacokinetics • Vol. 50, Issue 1 • 2025
PMID: 39652202PMC: PMC11802711DOI: 10.1007/s13318-024-00926-z

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact